Oragenics CMO Dr. James Kelly to speak at 12th Annual Brain Health Summit on Feb 8, 2025

ORAGENICS INC

Dr. James P. Kelly, Oragenics CMO, will be a featured panelist at the 12th Annual Brain Health Summit on Feb 8, 2025 in New Orleans.
Summit focuses on awareness, prevention, and care for athletic concussions and traumatic brain injury (TBI) treatment.
Oragenics is developing ONP-002, an intranasal neurosteroid for concussion treatment, which Dr. Kelly will discuss.
Event is hosted by sports agent Leigh Steinberg during Super Bowl celebrations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.